Chinese Pharma Tycoon Looks For Overseas Health-Care DealsBloomberg News
Luye Group seeks to buy hospitals overseas to gain new brands
Liu wants to tap rising Chinese demand for better health care
Liu Dian Bo, chairman of China’s Luye Group Ltd., is on a hunt for health-care businesses to acquire overseas as he seeks to expand beyond pharmaceuticals and tap rising demand from more affluent Chinese for higher-quality services.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.